93
Views
25
CrossRef citations to date
0
Altmetric
SUPPLEMENT: TENTH INTERNATIONAL MAGNESIUM SYMPOSIUM

A Substance P Antagonist Increases Brain Intracellular Free Magnesium Concentration after Diffuse Traumatic Brain Injury in Rats

, PhD, , , , PhD &
Pages 538S-540S | Received 05 Aug 2004, Published online: 18 Jun 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ibolja Cernak. (2006) Recent advances in neuroprotection for treating traumatic brain injury. Expert Opinion on Investigational Drugs 15:11, pages 1371-1381.
Read now

Articles from other publishers (24)

Robert Vink & Frances Corrigan. (2023) The Role of Substance P and NK1 Receptors in Mild to Severe Traumatic Brain Injury: From CTE to ICP. Receptors 2:4, pages 220-231.
Crossref
Tingting Ma, Huanli Cheng, Tongxi Li, Yifan Chen, Tianying Cai, Junjie Bai, Ziming Wu, Xianming Xia, Tiancheng Liang, Yichao Du & Wenguang Fu. (2022) N-Acetyl-l-tryptophan inhibits CCl4-induced hepatic fibrogenesis via regulating TGF-β1/SMAD and Hippo/YAP1 signal. Bioorganic Chemistry 126, pages 105899.
Crossref
Joanna Matalińska & Piotr F.J. Lipiński. (2022) Correcting a widespread error: Neuroprotectant N-acetyl-L-tryptophan does not bind to the neurokinin-1 receptor. Molecular and Cellular Neuroscience 120, pages 103728.
Crossref
Jay H. Kramer, I. Tong Mak, Joanna J. Chmielinska, Christopher F. Spurney, Terry M. Phillips & William B. Weglicki. (2020) Experimental Hypomagnesemia Induces Neurogenic Inflammation and Cardiac Dysfunction. Hearts 1:2, pages 99-116.
Crossref
Huiting Li, Yitong Pan, Hongjuan Wu, Shuna Yu, Jianxin Wang, Jie Zheng, Can Wang, Jianguo Li & Jiying Jiang. (2020) Inhibition of excessive mitophagy by N-acetyl-L-tryptophan confers hepatoprotection against Ischemia-Reperfusion injury in rats. PeerJ 8, pages e8665.
Crossref
José Luís Alves, Joana Rato & Vitor Silva. (2019) Why Does Brain Trauma Research Fail?. World Neurosurgery 130, pages 115-121.
Crossref
Michal Ordak, Joanna Matras, Elzbieta Muszynska, Tadeusz Nasierowski & Magdalena Bujalska-Zadrozny. (2017) Magnesium in schizophrenia. Pharmacological Reports 69:5, pages 929-934.
Crossref
Annabel Sorby-Adams, Amanda Marcoionni, Eden Dempsey, Joshua Woenig & Renée Turner. (2017) The Role of Neurogenic Inflammation in Blood-Brain Barrier Disruption and Development of Cerebral Oedema Following Acute Central Nervous System (CNS) Injury. International Journal of Molecular Sciences 18:8, pages 1788.
Crossref
Sarah Hellewell, Bridgette D. Semple & Maria Cristina Morganti-Kossmann. (2016) Therapies negating neuroinflammation after brain trauma. Brain Research 1640, pages 36-56.
Crossref
F Corrigan, R Vink & R J Turner. (2016) Inflammation in acute CNS injury: a focus on the role of substance P. British Journal of Pharmacology 173:4, pages 703-715.
Crossref
Ana C. Sirianni, Jiying Jiang, Jiang Zeng, Lilly L. Mao, Shuanhu Zhou, Peter Sugarbaker, Xinmu Zhang, Wei Li, Robert M. Friedlander & Xin Wang. (2015) N-acetyl- l -tryptophan, but not N-acetyl- d -tryptophan, rescues neuronal cell death in models of amyotrophic lateral sclerosis . Journal of Neurochemistry 134:5, pages 956-968.
Crossref
Wei Li, Anastasios Fotinos, Qiaofeng Wu, Yanchun Chen, Yongjin Zhu, Sergei Baranov, Yanyang Tu, Edward W. Zhou, Bharati Sinha, Bruce S. Kristal & Xin Wang. (2015) N-acetyl-l-tryptophan delays disease onset and extends survival in an amyotrophic lateral sclerosis transgenic mouse model. Neurobiology of Disease 80, pages 93-103.
Crossref
Renée J. Turner & Robert Vink. (2014) NK1 tachykinin receptor treatment is superior to capsaicin pre-treatment in improving functional outcome following acute ischemic stroke. Neuropeptides 48:5, pages 267-272.
Crossref
José Luís Alves. (2013) Blood–brain barrier and traumatic brain injury. Journal of Neuroscience Research 92:2, pages 141-147.
Crossref
Zhao-Liang Sun & Dong-Fu Feng. (2013) Biomarkers of cognitive dysfunction in traumatic brain injury. Journal of Neural Transmission 121:1, pages 79-90.
Crossref
Renée Turner & Robert Vink. (2013) The Role of Substance P in Ischaemic Brain Injury. Brain Sciences 3:4, pages 123-142.
Crossref
Kate Marie Lewis, Renée Jade Turner & Robert Vink. (2013) Blocking Neurogenic Inflammation for the Treatment of Acute Disorders of the Central Nervous System. International Journal of Inflammation 2013, pages 1-16.
Crossref
R.J. Turner & R. Vink. (2012) Combined tissue plasminogen activator and an NK1 tachykinin receptor antagonist: An effective treatment for reperfusion injury following acute ischemic stroke in rats. Neuroscience 220, pages 1-10.
Crossref
Kate M. Lewis, Elizabeth Harford-Wright, Robert Vink & Mounir N. Ghabriel. (2012) Targeting classical but not neurogenic inflammation reduces peritumoral oedema in secondary brain tumours. Journal of Neuroimmunology 250:1-2, pages 59-65.
Crossref
Wojciech DabrowskiZiemowit Rzecki, Marek Czajkowski & Jacek Pilat. (2012) Magnesium reduces matrix metalloproteinase-9, but not glial fibrillary acidic protein, in cardiac surgery patients. Future Neurology 7:3, pages 349-359.
Crossref
James J. DonkinIbolja CernakPeter C. BlumbergsRobert Vink. (2011) A Substance P Antagonist Reduces Axonal Injury and Improves Neurologic Outcome When Administered Up to 12 Hours after Traumatic Brain Injury. Journal of Neurotrauma 28:2, pages 217-224.
Crossref
Emma Thornton, Jenna M Ziebell, Anna V Leonard & Robert Vink. (2010) Kinin Receptor Antagonists as Potential Neuroprotective Agents in Central Nervous System Injury. Molecules 15:9, pages 6598-6618.
Crossref
Robert Vink & Corinna Heuvel. (2010) Substance P antagonists as a therapeutic approach to improving outcome following traumatic brain injury. Neurotherapeutics 7:1, pages 74-80.
Crossref
Eugene S Fu & Ramachandra P Tummala. (2005) Neuroprotection in brain and spinal cord trauma. Current Opinion in Anaesthesiology 18:2, pages 181-187.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.